SLDB Solid Biosciences LLC
Company Analysis
Latest News
🟢 Solid Biosciences is trading 6.08% up today in pre-market after RBC initiated coverage with Outperform rating
Solid Biosciences is trading at $9.25, up 6.08% in pre-market after RBC Capital Markets initiated coverage with an Outperform rating. - The firm initiated...
🟢 Solid Biosciences is trading 6.69% up in pre-market with no clear company-specific announcement identified
Solid Biosciences is trading 6.69% up at $8.93 in pre-market, with no clear company-specific announcement identified for September 16, 2026. - Recent coverage...
🔴 Solid Biosciences falls 5.7% — Biotech Sector Declines on Key Drug Trial Failure and Shifting Investor Sentiment
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
🔴 Solid Biosciences is trading 5.6% down today as major U.S. indices fell more than 0.5%
Solid Biosciences is trading 5.6% down at $9.01 after three consecutive lower closes, as major U.S. indices fell more than 0.5% amid hotter producer inflation,...
🔴 Solid Biosciences is trading 5% down in pre-market after three consecutive lower closes
Solid Biosciences is trading at $9.05, down -5.14%, amid continued selling pressure after three consecutive lower closes. - No clear company-specific negative...
🔴 Solid Biosciences is trading 6.34% down today; no company-specific catalyst identified
Solid Biosciences is trading 6.34% down at $9.60, with no new company-specific catalyst identified for September 8, 2026. - The latest announcement concerns...
🟢 Solid Biosciences is trading 5% up today
Solid Biosciences is trading 5.06% up now at $10.38, with no clear company-specific catalyst identified. - No clear September 2, 2026, company-specific...
🟢 Solid Biosciences is trading 7.47% up in pre-market with no confirmed company-specific catalyst identified
Solid Biosciences is trading 7.47% up in pre-market at $10.50 after no confirmed company-specific catalyst was identified for August 31, 2026. - Latest...
🔴 Solid Biosciences is trading 5.1% down in pre-market; catalyst unconfirmed
Solid Biosciences is trading 5.13% down at $9.61, with no clear company-specific announcement, earnings release, regulatory decision, or analyst action...
🟢 Solid Biosciences is trading 5.3% up today amid broader market rally
Solid Biosciences is trading at $10.23, up 5.25%, primarily amid a strong growth-stock rally. - Nasdaq is up 1.33%, while the S&P 500 is up 0.53%. - No new...
🔴 Solid Biosciences is trading 6.91% down in pre-market — no new company-specific catalyst identified
Solid Biosciences is trading 6.91% down at $9.05 after its $9.72 close on August 26, 2026; no new company-specific announcement, earnings release, regulatory...
🔴 Solid Biosciences is trading 9% down today in pre-market
Solid Biosciences is trading 9% down at $9.00 in pre-market after closing at $9.89 on August 25, 2026; no clear catalyst was identified for August 26. - The...
🟢 Solid Biosciences rises 5.3% — Biotech Sector Gains Amid Broad Market Rally and Positive Sentiment
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, represented by the XBI ETF, is...
🟢 Solid Biosciences rises 5.2% — Biotech Sector Continues Upward Trend on Strong Momentum
With Biotech (XBI) up 2.0%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🔴 Solid Biosciences falls 5.2% — Biotech Sector Cools Off After Moderna-Sparked Rally
With Biotech (XBI) down 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a pullback after a...
🔴 Solid Biosciences is trading 7.5% down in pre-market following prior-session gain; catalyst unclear
Solid Biosciences is trading 7.5% down at $9.01, with the immediate catalyst unclear after a 7.27% prior-session gain. - Shares reached $9.74 on August 19. -...
🟢 Solid Biosciences rises 5.9% — Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results
With Biotech (XBI) up 3.7%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, proxied by the XBI ETF, is trading...
🔴 Solid Biosciences is trading 5% down in pre-market amid weaker risk sentiment
Solid Biosciences is trading 5.38% down now at $8.61, primarily amid weaker risk sentiment; no major company-specific announcement was identified for August...
🔴 Solid Biosciences is trading 6% down in pre-market with no major company-specific announcement identified
Solid Biosciences is trading at $8.65 (-5.98%) with no major company-specific announcement identified for August 17, 2026. - The latest notable developments...
🔴 Solid Biosciences is trading 5.3% down today in pre-market with no clear company-specific catalyst identified
Solid Biosciences is trading 5.29% down at $8.60 in the August 14, 2026 pre-market, with no clear company-specific catalyst identified. - Its latest notable...